Publicaciones en colaboración con investigadoras/es de Instituto de Salud Carlos III (8)

2022

  1. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

    Frontiers in Immunology, Vol. 13

  2. One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics

    RSC Advances, Vol. 12, Núm. 43, pp. 27963-27969

  3. Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases

    Journal of Alzheimer's Disease, Vol. 87, Núm. 4, pp. 1497-1501

2021

  1. 3D bioprinting of functional skin substitutes: From current achievements to future goals

    Pharmaceuticals, Vol. 14, Núm. 4

  2. Cost-effectiveness analysis of text messaging to support health advice for smoking cessation

    Cost Effectiveness and Resource Allocation, Vol. 19, Núm. 1

  3. Intrapericardial delivery of apa-microcapsules as promising stem cell therapy carriers in an experimental acute myocardial infarction model

    Pharmaceutics, Vol. 13, Núm. 11

2018

  1. Tunable injectable alginate-based hydrogel for cell therapy in Type 1 Diabetes Mellitus

    International Journal of Biological Macromolecules, Vol. 107, Núm. PartA, pp. 1261-1269

2017

  1. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138